Scarica l'app Stockscreener
8.61
7.10%
0.585
Precedente Chiudi:
$8.025
Aprire:
$8.24
Volume 24 ore:
387.31K
Relative Volume:
1.33
Capitalizzazione di mercato:
$2.50B
Reddito:
$391.87M
Utile/perdita netta:
$-441.45M
Rapporto P/E:
-4.6541
EPS:
-1.85
Flusso di cassa netto:
$-301.21M
1 W Prestazione:
+0.88%
1M Prestazione:
-0.41%
6M Prestazione:
-31.68%
1 anno Prestazione:
-33.73%
Intervallo 1D:
$8.24
$8.8968
Intervallo di 1 settimana:
$7.81
$9.09
Portata 52W:
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
Confronta ALVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
8.60 | 2.50B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
154.28 | 68.30B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.12 | 47.37B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.695 | 43.29B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.20 | 20.49B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
315.15 | 14.16B | 2.99B | 1.21B | 1.13B | 25.06 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | UBS | Buy |
| 2024-01-29 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-09-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-07 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Downgrade | Citigroup | Buy → Sell |
| 2022-07-26 | Iniziato | Citigroup | Buy |
Mostra tutto
Alvotech Borsa (ALVO) Ultime notizie
Alvotech (NASDAQ:ALVO) Shares Gap Up on Earnings Beat - MarketBeat
Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in - MSN
What are Alvotech’s recent SEC filings showingWeekly Loss Report & Expert Approved Trade Ideas - kangso.co.kr
What’s the analyst consensus on AlvotechIPO Watch & Low Drawdown Trading Techniques - classian.co.kr
Alvotech (NASDAQ:ALVO) Announces Earnings Results - MarketBeat
Alvotech (NASDAQ:ALVO) Sees Strong Trading Volume Following Better-Than-Expected Earnings - MarketBeat
Can Alvotech weather a recessionWeekly Gains Summary & Comprehensive Market Scan Reports - mustnews.co.kr
Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships - MSN
Why Alvotech Shares Are Gaining Attention - TipRanks
Published on: 2025-08-16 00:15:42 - beatles.ru
Northland Securities Maintains Alvotech(ALVO.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
Alvotech Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Alvotech shares fall 3.13% premarket after H1 2025 earnings call. - AInvest
Alvotech Reports Strong Growth and Strategic Expansion - TipRanks
Alvotech targets 50% U.S. Humira biosimilar market share by year-end as Q2 product revenues rise 77% - MSN
Alvotech (ALVO) Expected to Announce Earnings on Wednesday - MarketBeat
Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships. - AInvest
Alvotech's Q2 2025: Navigating Contradictions in Market Share, Revenue Guidance, and FDA Inspections - AInvest
Alvotech shares fall 11.44% intraday despite strong H1 2025 earnings and revenue growth. - AInvest
Alvotech Plunges 9.5% Intraday: Can This Biosimilars Powerhouse Rebound From Debt-Driven Volatility? - AInvest
Transcript : Alvotech, H1 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Alvotech shares fall 2.34% premarket despite reporting strong H1 2025 earnings and product revenue growth. - AInvest
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update - Placera.se
Alvotech shares rise 2.68% premarket after reporting strong Q2 2025 results and 200% product revenue growth. - AInvest
Alvotech's Q1 Operating Income Surpassing $28.6M: A Catalyst for Long-Term Growth in a High-Potential Biosimilars Sector? - AInvest
Alvotech Posts $28.6M H1 Operating Income, Product Revenue Rises - AInvest
Alvotech H1 operating income USD 28.639 million - MarketScreener
Alvotech (ALVO) Is Up 5.9% After Swinging to Profit in H1 2025What's Changed - simplywall.st
Alvotech's Strategic Transformation and Financial Turnaround: A High-Conviction Buy Opportunity in Biosimilars - AInvest
Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Why Alvotech Shares Are Under Pressure - TipRanks
Alvotech earnings beat by $0.50, revenue topped estimates - Investing.com Nigeria
ALVOTECH Earnings Results: $ALVO Reports Quarterly Earnings - Quiver Quantitative
Alvotech soars as product revenue surges over 200% YoY By Investing.com - Investing.com Australia
Alvotech soars as product revenue surges over 200% YoY - Investing.com India
Alvotech : Q2 2025Unaudited Condensed Consolidated Interim Financial Statements first 6 months - MarketScreener
Alvotech Reports Q2 Non-GAAP EPS of $0.49, Beating Estimates by $0.49, with Product Revenue Reaching $204.7 Million. - AInvest
Alvotech Reports Record Growth with 200% Increase in Product Revenues Year-on-Year and Best Quarter for Operating Cash Flows - Quiver Quantitative
Alvotech - Via Ritzau
Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet - sharewise.com
Why Alvotech stock attracts strong analyst attentionMarket Trend Summary & Fast Moving Market Watchlists - thegnnews.com
Alvotech to Report Q2 2025 Earnings on August 13, 2025, with Webcast on August 14, 2025 - AInvest
Alvotech's Q2 Earnings Preview: Analysts Expect $-0.11 EPS, Share Price Down 21.99% Over 52-Week Period - AInvest
Alvotech Rebounds From Oversold Zone — Now WhatAccurate Technical Trend Reversal Picks Detected - 선데이타임즈
Regression Model Predicts Rangebound Movement in AlvotechBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
MACD Signals Flash Warning for Alvotech StockLow Risk High Return Opportunities Identified - beatles.ru
Alvotech WRT ALVOW 2025Q2 Earnings Preview Upside Ahead on Revenue Growth Forecast - AInvest
Alvotech ALVO 2025Q2 Earnings Preview Upside Potential Driven by Strategic Partnerships - AInvest
Screener Results Flag Alvotech as OversoldCapital Preserving Trade Plan Templates Shared - metal.it
What makes Alvotech stock price move sharplyTop 100 Low Volatility Gainers - thegnnews.com
Who’s Hired? Rosemont Gains A Chairperson But Loses A CEO - insights.citeline.com
Alvotech Azioni (ALVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):